baber/WOPTO huggingface dataset:
Patent NZ-507383-A (NZ)
Title: Conjugated dextran-haemoglobin as blood substitutes preferably with MW about 100-200 KDa with the haemoglobin covalently cross-linked to the dextran by secondary amine linkages
Inventor: ADAMSON GORDON W
IPC: A61K47/61
Filed: 1999-03-25
Abstract: Disclosed is a process for preparing hemoglobin- polysaccharide conjugates useful as hemoglobin-based oxygen carriers by (a) Subjecting a starting polysaccharide, such as hydroxyethyl starch or dextran, to oxidative ring-opening to produce an oxidatively ring-opened polysaccharide carrying aldehyde groups; (b) Reacting said oxidatively ring-opened polysaccharide with a hemoglobin under conditions suitable to form Schiff base linkages between the hemoglobin and the oxidatively ring-opened polysaccharide to from an initial hemoglobin- polysaccharide conjugate composition containing oxidized polysaccharides; (c) Degrading the oxidatively ring-opened polysaccharide by maintaining the conjugate composition under controlled conditions of aqueous solution with predetermined pH for a period of time until a desired lower average molecular weight hemoglobin-polysaccharide conjugate composition as compared to the initial hemoglobin-polysaccharide conjugate composition is reached, to form a detectable degraded further hemoglobin-polysaccharide conjugate composition with a lowered average molecular weight, a lowered amount of unreacted hemoglobin species as compared to the initial hemoglobin-polysaccharide conjugate composition (d) Reducing the further hemoglobin-polysaccharide conjugate composition once desired lower molecular weight is reached to form a reduced hemoglobin-polysaccharide conjugate composition; and (e) Recovering said reduced hemoglobin-polysaccharide conjugate composition. Reduced hemoglobin-polysaccharide conjugate compositions produced by this process are also claimed, and are useful as blood substitutes or supplements.
Patent NZ-508508-A (NZ)
Title: Application of polymethylhydrogen siloxane emulsion for producing a water resistant gypsum product and gypsum/wood fiber board and gypsum board
Inventor: MAO ZHUOXIONG
IPC: C04B28/14
Filed: 2000-11-29
Abstract: A process for making a gypsum containing board product having water resistance which comprises: Adding an aqueous siloxane emulsion and Portland cement to an aqueous slurry of calcium sulfate hemihydrate material and host particles, which slurry is at a temperature above the rehydration temperature, the siloxane emulsion and Portland cement being stable under conditions in which calcium sulfate hemihydrate crystals are formed; Passing the siloxane-containing slurry onto a porous forming surface to form a filter cake before the temperature of the filter cake falls below the temperature at which the calcium sulfate hemihydrate rehydrates to calcium sulfate dihyrdrate; Removing a substantial portion of the water from the filter cake through the porous surface and cooling the filter cake to a temperature at which rehydrating begins; Pressing the filter cake to form a board and remove additional water whereby calcium sulfate hemihydrate crystals; Heating and drying the board to remove the remaining free water and to cause the core of the board to reach a temperature sufficient to cure the siloxane to form polymerized silicone.
Patent NZ-512807-A (NZ)
Title: Compositions and methods for enhancement of major histocompatibility complex class 1 restricted antigen presentation by attaching the antigen to a specific peptide
Inventor: LAUS REINER
IPC: C07K19/00
Filed: 1999-12-14
Abstract: Compositions and methods for eliciting an in vivo cytotoxic lymphocyte (CTL) response against a modified soluble protein antigen are disclosed. The modified soluble protein antigen comprises an added peptide sequence that facilitates entry of the modified antigen into antigen presenting cells (APC). Such compositions and methods are useful for promoting an immune response to a the antigen, and in particular for treating cancer.
Patent NZ-513034-A (NZ)
Title: Method for synchronising product presentation with customer needs
Inventor: FORD TIMOTHY
IPC: G06Q30/00
Filed: 1999-12-24
Abstract: An integrated method for marketing products, said method including steps of: a) obtaining information about a customer from the customer to generate a customer profile; b) analysing the information to determine the likely existing and future needs of the customer and to determine the approximate times at which said future needs will arise; c) recording the determined needs and diarising said approximate items, so that the customer may be contacted at, or prior to, the approximate times regarding the determined needs.
Patent NZ-515890-A (NZ)
Title: Preparing a reprogrammed diploid cell by nuclear addition where the donor nucleus is placed into an intact cell and exposed to reprogramming factors
Inventor: BRANDON MALCOLM ROY
IPC: G01N33/48
Filed: 2000-05-05
Abstract: Described is the reprogramming of a non-human adult cell nucleus to produce an embryo. The process involves: taking a donor cell or nucleus; fusing the donor nucleus with a recipient cell that has not been enucleated to produce an aneuploid cell; waiting a period of time to allow the donor nucleus to be reprogrammed; and then removing the recipient cell nucleus. This process results in a non-human embryo with a reprogrammed nucleus.
Patent NZ-520254-A (NZ)
Title: A process for applying colour on cementitious surface by marking grid and using stencil to colour inside of grid cells, to create tile pattern
Inventor: MARSHALL IVAN
IPC: B44F9/04
Filed: 2002-07-18
Abstract: A process for creating a substantially tile pattern on a cementitious surface, comprising the steps of: a) marking the surface in a plurality of cells which together substantially form a grid, b) taking a stencil and laying it on or adjacent one of the cells to substantially cover or align with a perimeter of the cell while leaving a central part of that cell uncovered, c) applying colour to the uncovered central part of the cell, d) removing the stencil from the cell, and e) repeating steps b) to d) for others of the cells to create a substantially tile pattern on the cementitious surface.
Patent NZ-521227-A (NZ)
Title: Trifluorobutenes their preparation and use as a nematicidal agent
Inventor: WATANABE YUKIYOSHI
IPC: A01N43/76
Filed: 2001-03-08
Abstract: Trifluorobutenes of the formula (I), processes for their preparation and their use as nematicides is disclosed, wherein R1 represents hydrogen, halogen, or C1-6 alkyl which may be unsubstituted or substituted with halogen, hydroxy, C1-3 alkoxy, C1-3 alkylthio, C1-3 alkylcarbonyloxy, trifluoromethylcarbonyl-oxy or cyano, or represents C1-4 alkylsulfonyloxy or represents phenyl which may be unsubstituted or substituted with halogen, alkyl, haloalkyl, alkoxy, alkylthio, alkylsulfonyl, haloalkoxy, haloalkylthio, phenyl, phenoxy, cyano or nitro; R2 represents hydrogen, halogen, or C1-6 alkyl which may be unsubstituted or substituted with C1-3 alkoxy or halogen, or represents C1-4 alkoxycarbonyl, and n represents 0, 1 or 2.
Patent NZ-521424-A (NZ)
Title: Catalytic conversion of alkanes to alkenes
Inventor: LEGENDRE OLIVIER
IPC: C07B61/00
Filed: 2001-03-23
Abstract: A process for the catalytic reaction of a C2 to C5 alkane and elemental sulphur to produce the corresponding alkene and hydrogen sulfide. The reaction mixture is contacted with a catalyst at a temperature of from 300 to 650oC. The catalyst has a surface area greater than 100 square meters per gram. The selectivity of the process to alkene is greater than 90%, and the process is carried out at a space velocity of from 50 to 5000h-1.
Patent NZ-522018-A (NZ)
Title: Reverse molded fibreboard panel
Inventor: LYNCH STEVEN K
IPC: B27N3/08
Filed: 2001-01-09
Abstract: A reverse molded fiberboard panel (12); a wainscot  kit comprising  a plurality of differently sized reverse  molded panels  (12),  and  a  planar  finishing  or  spacer  panel, adapted  to  completely cover any size wall between  a  wall base  board  and a wall chair rail; and a method of  reverse molding  a loose cellulosic mat, in a single pressing  step, to  provide  one  or  more relatively high  density,  raised panels  (12)  without  requiring  preliminary  pressing,  or other  pre-shaping  step,  such as  scalping.  The  reverse- molded  panels  (12)  are molded in a  conventional,  multi- opening   fiberboard  press,  in  a  single  pressing   step process,  while achieving excellent transfer of mold  detail (embossing  fidelity)  without  visually  noticeable   fiber fracture.
Patent NZ-524340-A (NZ)
Title: Back portion for chair with frame sides resilient movement confined to front and rear directions
Inventor: FOOTITT IAN COLIN
IPC: A47C1/032
Filed: 2001-09-03
Abstract: The chair back portion has sides 38 with neutral axes of bending close to the front surface of the frame. A resilient flexible member (not shown) is attached to and drawn tautly over the frame opening. (62) Divided out of 513927
Patent NZ-527002-A (NZ)
Title: Electrical socket fitting rotatable cover with radially biased hinge for catch engagement in closed position
Inventor: COOK QUENTIN DAVID
IPC: H01R13/52
Filed: 2003-07-14
Abstract: Electrical socket fitting 10 has pivotal flap 17 which can be rotated between open and closed positions. Pivot 20 is biased radially outwards so that catch parts 28 and 29 remain engaged.
Patent NZ-528320-A (NZ)
Title: Composition for inducing cartilaginous tissue formation and maintenance comprising a non-culture expanded CD105+ cells and a BMP
Inventor: MAJUMDAR MANAS KUMAR
IPC: C12N5/09
Filed: 2002-02-19
Abstract: Compositions of bone morphogenetic proteins (BMPs) useful for cartilage repair and methods employing these compositions are disclosed. Compositions comprising non-tissue culture expanded CD105+ cells isolated from bone marrow and treated with BMPs useful for cartilage repair and methods employing these compositions are also disclosed. The compositions are useful in the treatment of osteoarthritis, cartilage defects and in related tissue repair as they induce cartilaginous tissue formation and maintenance.
Patent NZ-529223-A (NZ)
Title: Improvements in receivers for television signals
Inventor: BODKIN NIGEL
IPC: H04N5/00
Filed: 2000-08-09
Abstract: A receiver for receiving signals representative of television programmes in a plurality of channels comprises: a first tuner for receiving signals in a first channel and a first data buffer for buffering data representative of signals received by the first tuner; a second tuner for simultaneously receiving signals in a second channel and a second data buffer for buffering data representative of signals received by the second tuner; a recorder for recording data representative of signals in the first and the second channel received simultaneously by the first tuner and the second tuner; a third data buffer for buffering data from the recorder representative of television pictures to be displayed on a television screen and a processor for selectively causing data to be transferred from the first data buffer or the second data buffer to the recorder for recording the transferred data and to transfer data from the recorder to the third data buffer. The recorder is operable successively to record data buffered in the first and the second data buffer and to transfer data from the recorder to the third data buffer. The successively stored and transferred data is representative of signals simultaneously received by the first and the second tuners and output from the third data buffer, respectively. A receiver for receiving signals representative of television programmes in a plurality of channels comprises: a first tuner for receiving signals representing a first television programme in a first channel and a second tuner for simultaneously receiving signals representing a second television programme in a second channel and a recorder arranged simultaneously to record data representative of signals in the first and the second channel received by the first tuner and the second tuner and to play back a third, previously recorded television programme, wherein the third television programme is selectable for play back from the recorder independently from the first and second television programmes. (62) Divided out of 517056
Patent NZ-530188-A (NZ)
Title: Integrated process for producing liquid hydrocarbons
Inventor: DE GRAAF WINNIFRED
IPC: C10G2/00
Filed: 2002-06-24
Abstract: Process for producing liquid hydrocarbons from a hydrocarbonaceous feedstock is disclosed, which comprises the following steps: (i) catalytically reforming at least part of the hydrocarbonaceous feedstock at elevated temperature and pressure with steam in at least one reforming zone; (ii) heating the reforming zone (s) by means of a carbon dioxide containing heating gas comprising a product obtained by partial oxidation of reformer product obtained in step (i) and carbon dioxide depleted light product obtained in step (vi) with an oxygen-containing gas in an oxidation zone; (iii) separating carbon dioxide from cooled down heating gas obtained in step (ii); (iv) catalytically converting at least part of the carbon dioxide depleted gas stream obtained in step (iii) at elevated temperature and pressure into normally liquid hydrocarbons; (v) separating product stream obtained in step (iv) into a light product comprising mainly unconverted synthesis gas, inerts and light hydrocarbons and a heavy product comprising mainly normally liquid and solid hydrocarbons; (vi) separating carbon dioxide from light product obtained in step (v); and (vii) combining at least part of the carbon dioxide feed obtained in step (iii) and/or step (vi) with hydrocarbonaceous for step (i).
Patent NZ-538109-A (NZ)
Title: Therapeutic treatment for vegf related occular diseases
Inventor: AIELLO LLOYD P
IPC: A61K31/00
Filed: 1997-05-01
Abstract: Disclosed is the use of compounds of formula (I) (wherein the substituents are as described in the specification) for the manufacture of a medicament for treating an ocular vascular disorder, wherein the ocular vascular disorder is selected from the group consisting of macular degeneration, macular edema, vascular retinopathy, iris neovascularization, retinal vein occlusion, histoplasmosis, and ischemic retinal disease. (62) Divided Out of 504719
Patent NZ-538556-A (NZ)
Title: Method for high-frequency tuning an electrical device and a printed circuit board suitable therefor
Inventor: GRAHAM NEIL DERYCK BRAY
IPC: F16L55/16
Filed: 2003-09-02
Abstract: An apparatus (10) for lining an internal surface of a pipeline (15) or other conduit is disclosed. The apparatus (10) comprises an installation head (21) which is progressively moved along the pipeline (15) for installing a flexible liner (11) onto the interior surface (13) of the pipeline (15). The flexible liner (11) comprises a tube structure (17) undergoing eversion within the pipeline (15). The tube structure (17) comprises a resin absorbent material. The installation head (21) has a contact surface (23) against which the tube structure (17) acts during eversion thereof, the contact surface (23) having means for delivery of a curable resin to the everting portion of the tube. The installation head (21) advances along the pipeline (15) under the influence of a driving force comprising (at least in part) pressure applied to the installation head (21) through the everting tube structure (17).
Patent NZ-539497-A (NZ)
Title: Bedmat sensor for attachment to enuresis alarm
Inventor: BROWNE REX LESLIE
Filed: 2005-04-19
Abstract: A mat for use with a bedwetting alarm is disclosed. The mat is constructed from a rubber sheet (1) that has stainless steel wires (2) woven into it so that the presence of moisture will complete a circuit connected to the end terminals (4) of the wires.
Patent NZ-540849-A (NZ)
Title: Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
Inventor: ALTMANN EVA
IPC: C07C323/25
Filed: 2003-12-22
Abstract: Disclosed are derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone. Also disclosed is the use of these derivatives or a pharamaceutically-acceptable and -cleavable ester, or acid addition salt thereof for the preparation of a pharmaceutical preparation for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable, as well as other conditions.
Patent NZ-542521-A (NZ)
Title: Improvements relating to graphical user interfaces
Inventor: STEIN MICHAEL LEWIS
IPC: G06F9/44
Filed: 2004-03-24
Abstract: A graphical user interface (GUI) for facilitating user interaction with a workflow process is disclosed. The GUI includes: (a) a page which includes a map comprising a plurality of interlinked nodes which graphically represent the structure of a plurality of interlinked steps of a stored workflow process, (b) data entry means for entering data relating to a particular selected node, where the data entry means comprises a display means for graphically displaying, within a portion of the page, a predetermined data entry request and a response made by the user to the request, (c) data recording means for storing the user response to the request in a data record, (d) pathway means for specifying a particular pathway across the map, where the pathway comprises two or more of the plurality of interlinked nodes, wherein each node has a unique relationship with a step in the workflow process and the pathway means is arranged to use the user response stored in the data record to specify a next step within the workflow process, and (e) graphical means for graphically representing in the page a pathway across the map selected by the user, where previously executed steps in the workflow process are readily apparent to the user from viewing the page.
Patent NZ-550263-A (NZ)
Title: Improvements relating to socks
Inventor: ADAMS SIMON MARK
IPC: A44B11/02
Filed: 2005-03-30
Abstract: A compression therapy kit comprises a sock (101a, 101b) suitable for wearing on a limb of a patient. The sock comprises material having the ability to wick moisture away from the skin surface and the sock comprises padding (107, 108) located in those areas of the sock which in use will cover the ankle and shin of the patient and one or more compression applying means which in use apply compression over the sock to the ankle and shin of the patient.
Patent NZ-551668-A (NZ)
Title: Combinations comprising an antimuscarinic agent (aclidinium) and PDE4 inhibitors
Inventor: GRAS ESCARDO JORDI
IPC: A61K45/00
Filed: 2005-05-31
Abstract: Disclosed is a combination comprising a PDE4 inhibitor and 3(R)-(2-hydroxy-2,2dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane, also known as aclidinium, in salt form having an anion which is a pharmaceutically acceptable anion of a mono or polyvalent acid. Also disclosed is the use of the above combination for treating a respiratory disease which responds to M3 antagonism, such as asthma or chronic obstructive pulmonary disease (COPD).
Patent NZ-563174-A (NZ)
Title: Method and apparatus for remotely controlling electrically powered accessories by way of a digital signal impressed onto the power cable of the accessory to be controlled
Inventor: CHEN GANG
IPC: H04B3/54
Filed: 2007-11-05
Abstract: A control system for vehicle accessories or similar items remote from the controls is disclosed. The control system is connected via the power connection to the accessories, where the control signal is a pulse train impressed on the power connection. The modulation may be a frequency shift keyed waveform and each accessory may have a differing binary address.
Patent NZ-563493-A (NZ)
Title: Use of an anti-CTGF agent for the treatment of a vascular dysfunction in a patient
Inventor: LANGSETMO PAROBOK INGRID
IPC: A61K39/395
Filed: 2006-05-05
Abstract: Discloses is the use of an effective amount of an anti-CTGF agent selected from the group consisting of: an antibody that binds to CTGF, or an anti-CTGF fragment thereof; an anti-CTGF antisense molecule; or an anti-CTGF siRNA for the manufacture of a medicament for reducing a vascular dysfunction in a subject, wherein the vascular dysfunction is selected from vascular permeability or extravasation.
Patent NZ-568429-A (NZ)
Title: Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
Inventor: PIENE JAN YNGVAR
IPC: A23L33/155
Filed: 2006-12-07
Abstract: Disclosed herein is a method for the preparation of a granulated calcium-containing compound wherein the calcium-containing compound is selected from the group consisting of calcium carbonate, calcium citrate, calcium lactate, calcium phosphate including tricalcium phosphate, calcium gluconate, bisglycino calcium, calcium citrate maleate, hydroxyapatite including solvates thereof and mixtures thereof in a concentration of 50% w/w or more and in the form of particles and/or crystals, the method comprising applying a granulating composition comprising i) one or more water-soluble substances selected from the group consisting of polyols and carbohydrates, and ii) one or more polymeric substances selected from the group consisting of povidones and copovidones, and mixtures thereof, to a calcium-containing compound, and the water-soluble substance and the polymeric substance are dispersed or dissolved in a solvent. Also disclosed is a partly film-coated calcium-containing compound, wherein the calcium-containing compound is in the form of particles and/or crystals having at least part water-soluble film coating comprising i) one or more water-soluble substances selected from the group consisting of polyols and carbohydrates, and ii) one or more polymeric substances selected from the group consisting of povidones and copovidones, and mixtures thereof.
Patent NZ-568550-A (NZ)
Title: Polymorphs of androgen receptor modulator N-(3H-imidazo[4,5-B]pyridin-2-ylmethyl)-2-fluoro-4-methyl-3-oxo-4-aza-5-alpha-androst-1-en-17-beta-carboxamide
Inventor: TAN LUSHI
IPC: A61K31/58
Filed: 2006-12-04
Abstract: The disclosure relates to crystalline polymorphic, pseudopolymorphic and amorphous solid state forms of N-(3H-imidazo[4,5-B]pyridin-2-ylmethyl)-2-fluoro-4-methyl-3-oxo-4-aza-5-alpha-androst-1-en-17-beta-carboxamide represented by structural formula (I), which are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the treatment of conditions caused by androgen deficiency or which can be ameliorated by androgen administration, including osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism, postmenopausal symptoms in women, atherosclerosis, hypercholesterolemia, hyperlipidemia, obesity, aplastic anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, benign prostatic hyperplasia (BPH), abdominal adiposity, metabolic syndrome, type II diabetes, cancer cachexia, Alzheimer's disease, muscular dystrophies, cognitive decline, sexual dysfunction, sleep apnea, depression, premature ovarian failure, and autoimmune disease, alone or in combination with other active agents.